Nightingale Health Plc appointed Jeffrey Barrett as Chief Scientific Officer. Barrett will join Nightingale's management team as of 27 September 2021. Barrett is joining Nightingale with a key strategic role translating scientific discoveries from Nightingale's health data assets into commercial products. He will also help define Nightingale's future strategic initiatives to further accelerate Nightingale's global leadership in preventative health solutions. Jeffrey Barrett joins Nightingale from the Wellcome Sanger Institute.